CAMG
DGX icon

CWA Asset Management Group’s Quest Diagnostics DGX Stock Holding History

CWA Asset Management Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,217
Closed -$232K – 669
2025
Q3 		$232K Buy
+1,217
New +$216K 0.01% 609

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CWA Asset Management Group's DGX Position: Q4 2025 in Review

CWA Asset Management Group sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 1,217 shares — an estimated $232K sold.

CWA Asset Management Group first reported a position in DGX in Q3 2025 and held it in 1 quarter. The position peaked at $232K in Q3 2025. 1,049 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

  • CWA Asset Management Group reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
  • CWA Asset Management Group sold 1,217 Quest Diagnostics shares in Q4 2025, an estimated $232K.
  • CWA Asset Management Group first reported a position in Quest Diagnostics in Q3 2025 and held it in 1 quarter.
  • CWA Asset Management Group's Quest Diagnostics position peaked at $232K in Q3 2025.
  • 1,049 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on CWA Asset Management Group's 13F filing for Q4 2025, filed 7 Jan 2026.